PE anti-human CD63 Antibody
- 产品名称：
- PE anti-human CD63 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 353003
- 产品应用：
- 353003
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1356 |
1 |
- Verified Reactivity
- Human
- Reported Reactivity
- African Green, Baboon, Cynomolgus, Rhesus
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- T cell line HPB-ALL
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography and conjugated with PE under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
Additional reported applications (for the relevant formats) include: Western blotting1, immunofluorescence2, and immunoprecipitation1.
- Application References
(PubMed link indicates BioLegend citation) -
- Hildreth JE, et al. 1991. Blood 77:121. (IP, WB)
- Beatty WL, et al. 2006. J. Cell Sci. 119:350. (IF)
- Product Citations
-
- Margaroli C, et al. 2021. Cell Reports Medicine. 2(4):100239. PubMed
- Palkowitz AL, et al. 2021. Adv Healthc Mater. 10:e2100132. PubMed
- Mastoridis S, et al. 2021. Am J Transplant. 21:2387. PubMed
- Sung SE, et al. 2021. Int J Mol Sci. 22:. PubMed
- Khan K, et al. 2022. J Tissue Eng Regen Med. 16:110. PubMed
- Salybekov AA, et al. 2021. Front Cardiovasc Med. 8:754254. PubMed
- Nazari-Shafti TZ, et al. 2020. Biomolecules. 10:00. PubMed
- Balbi C, et al. 2021. EBioMedicine. 67:103369. PubMed
- Schanin J, et al. 2022. Commun Biol. 5:1226. PubMed
- Ponath V, et al. 2021. Int J Mol Sci. 22:. PubMed
- DeWeirdt PC, et al. 2020. Nat Biotechnol. . PubMed
- Liu JF, et al. 2022. Biomed Res Int. 2022:9453270. PubMed
- Mastoridis S, et al. 2018. Front Immunol. 1.474305556. PubMed
- Plum T, et al. 2020. Immunity. 52(2):404-416. PubMed
- Ding L, et al. 2018. Carcinogenesis. 39:397. PubMed
- RRID
- AB_10896786 (BioLegend Cat. No. 353003) AB_10897809 (BioLegend Cat. No. 353004)
- Structure
- Tetraspan transmembrane superfamily (TM4SF), type III lysosomal glycoprotein, 53 kD
- Distribution
-
Activated platelets, monocytes, macrophages, endothelium, fibroblasts, osteoclasts, and smooth muscle
- Function
- Platelet activation
- Interaction
- CD9, CD81, VLA-3, and VLA-6
- Cell Type
- B cells, Endothelial cells, Fibroblasts, Macrophages, Monocytes, Osteoclasts, Platelets
- Biology Area
- Cell Adhesion, Cell Biology, Immunology
- Molecular Family
- Adhesion Molecules, CD Molecules
- Antigen References
-
- Azorsa DO, et al. 1991. Blood 78:280.
- Kishimoto T, et al. Eds. 1997. Leukocyte Typing V1. Oxford University Press New York.
- Hildreth JE, et al. 1991. Blood 77:121.
- Anzai N, et al. 2002. Blood 99:4413.
- Gene ID
- 967 View all products for this Gene ID
- UniProt
- View information about CD63 on UniProt.org
